The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nitric Oxide Therapy System-Global Market Insights and Sales Trends 2025
Synopsis
Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
The global Nitric Oxide Therapy System market size is expected to reach US$ 46 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Nitric Oxide Therapy System in various end use industries. The expanding demands from the Hospitals, Homecare Settings and Others,, are propelling Nitric Oxide Therapy System market. Protable System, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fixed System segment is estimated at % CAGR for the next seven-year period.
Global Nitric Oxide Therapy System key players include Linde Group, Mallinckrodt Pharmaceuticals, Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health, etc. In terms of product, Fixed System is the largest segment, with a share about 90%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nitric Oxide Therapy System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nitric Oxide Therapy System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nitric Oxide Therapy System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nitric Oxide Therapy System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nitric Oxide Therapy System covered in this report include Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health, EKU Elektronik GmbH, GeNO LLC, International Biomedical, SLE, Mallinckrodt Pharmaceuticals and Praxair,, etc.
The global Nitric Oxide Therapy System market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bellerophon Therapeutics
BOC Healthcare
Dan Hammer Health
EKU Elektronik GmbH
GeNO LLC
International Biomedical
SLE
Mallinckrodt Pharmaceuticals
Praxair,
Vapotherm
Linde Group
Global Nitric Oxide Therapy System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nitric Oxide Therapy System market, Segment by Type:
Protable System
Fixed System
Global Nitric Oxide Therapy System market, by Application
Hospitals
Homecare Settings
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nitric Oxide Therapy System companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
The global Nitric Oxide Therapy System market size is expected to reach US$ 46 million by 2029, growing at a CAGR of 5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Nitric Oxide Therapy System in various end use industries. The expanding demands from the Hospitals, Homecare Settings and Others,, are propelling Nitric Oxide Therapy System market. Protable System, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fixed System segment is estimated at % CAGR for the next seven-year period.
Global Nitric Oxide Therapy System key players include Linde Group, Mallinckrodt Pharmaceuticals, Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health, etc. In terms of product, Fixed System is the largest segment, with a share about 90%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nitric Oxide Therapy System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nitric Oxide Therapy System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nitric Oxide Therapy System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nitric Oxide Therapy System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nitric Oxide Therapy System covered in this report include Bellerophon Therapeutics, BOC Healthcare, Dan Hammer Health, EKU Elektronik GmbH, GeNO LLC, International Biomedical, SLE, Mallinckrodt Pharmaceuticals and Praxair,, etc.
The global Nitric Oxide Therapy System market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bellerophon Therapeutics
BOC Healthcare
Dan Hammer Health
EKU Elektronik GmbH
GeNO LLC
International Biomedical
SLE
Mallinckrodt Pharmaceuticals
Praxair,
Vapotherm
Linde Group
Global Nitric Oxide Therapy System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nitric Oxide Therapy System market, Segment by Type:
Protable System
Fixed System
Global Nitric Oxide Therapy System market, by Application
Hospitals
Homecare Settings
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nitric Oxide Therapy System companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nitric Oxide Therapy System
1.1 Nitric Oxide Therapy System Market Overview
1.1.1 Nitric Oxide Therapy System Product Scope
1.1.2 Nitric Oxide Therapy System Market Status and Outlook
1.2 Global Nitric Oxide Therapy System Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nitric Oxide Therapy System Market Size by Region (2018-2029)
1.4 Global Nitric Oxide Therapy System Historic Market Size by Region (2018-2023)
1.5 Global Nitric Oxide Therapy System Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nitric Oxide Therapy System Market Size (2018-2029)
1.6.1 North America Nitric Oxide Therapy System Market Size (2018-2029)
1.6.2 Europe Nitric Oxide Therapy System Market Size (2018-2029)
1.6.3 Asia-Pacific Nitric Oxide Therapy System Market Size (2018-2029)
1.6.4 Latin America Nitric Oxide Therapy System Market Size (2018-2029)
1.6.5 Middle East & Africa Nitric Oxide Therapy System Market Size (2018-2029)
2 Nitric Oxide Therapy System Market by Type
2.1 Introduction
2.1.1 Protable System
2.1.2 Fixed System
2.2 Global Nitric Oxide Therapy System Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nitric Oxide Therapy System Historic Market Size by Type (2018-2023)
2.2.2 Global Nitric Oxide Therapy System Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nitric Oxide Therapy System Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nitric Oxide Therapy System Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nitric Oxide Therapy System Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nitric Oxide Therapy System Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nitric Oxide Therapy System Revenue Breakdown by Type (2018-2029)
3 Nitric Oxide Therapy System Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Homecare Settings
3.1.3 Others
3.2 Global Nitric Oxide Therapy System Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nitric Oxide Therapy System Historic Market Size by Application (2018-2023)
3.2.2 Global Nitric Oxide Therapy System Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nitric Oxide Therapy System Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nitric Oxide Therapy System Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nitric Oxide Therapy System Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nitric Oxide Therapy System Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nitric Oxide Therapy System Revenue Breakdown by Application (2018-2029)
4 Nitric Oxide Therapy System Competition Analysis by Players
4.1 Global Nitric Oxide Therapy System Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nitric Oxide Therapy System as of 2022)
4.3 Date of Key Players Enter into Nitric Oxide Therapy System Market
4.4 Global Top Players Nitric Oxide Therapy System Headquarters and Area Served
4.5 Key Players Nitric Oxide Therapy System Product Solution and Service
4.6 Competitive Status
4.6.1 Nitric Oxide Therapy System Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bellerophon Therapeutics
5.1.1 Bellerophon Therapeutics Profile
5.1.2 Bellerophon Therapeutics Main Business
5.1.3 Bellerophon Therapeutics Nitric Oxide Therapy System Products, Services and Solutions
5.1.4 Bellerophon Therapeutics Nitric Oxide Therapy System Revenue (US$ Million) & (2018-2023)
5.1.5 Bellerophon Therapeutics Recent Developments
5.2 BOC Healthcare
5.2.1 BOC Healthcare Profile
5.2.2 BOC Healthcare Main Business
5.2.3 BOC Healthcare Nitric Oxide Therapy System Products, Services and Solutions
5.2.4 BOC Healthcare Nitric Oxide Therapy System Revenue (US$ Million) & (2018-2023)
5.2.5 BOC Healthcare Recent Developments
5.3 Dan Hammer Health
5.3.1 Dan Hammer Health Profile
5.3.2 Dan Hammer Health Main Business
5.3.3 Dan Hammer Health Nitric Oxide Therapy System Products, Services and Solutions
5.3.4 Dan Hammer Health Nitric Oxide Therapy System Revenue (US$ Million) & (2018-2023)
5.3.5 EKU Elektronik GmbH Recent Developments
5.4 EKU Elektronik GmbH
5.4.1 EKU Elektronik GmbH Profile
5.4.2 EKU Elektronik GmbH Main Business
5.4.3 EKU Elektronik GmbH Nitric Oxide Therapy System Products, Services and Solutions
5.4.4 EKU Elektronik GmbH Nitric Oxide Therapy System Revenue (US$ Million) & (2018-2023)
5.4.5 EKU Elektronik GmbH Recent Developments
5.5 GeNO LLC
5.5.1 GeNO LLC Profile
5.5.2 GeNO LLC Main Business
5.5.3 GeNO LLC Nitric Oxide Therapy System Products, Services and Solutions
5.5.4 GeNO LLC Nitric Oxide Therapy System Revenue (US$ Million) & (2018-2023)
5.5.5 GeNO LLC Recent Developments
5.6 International Biomedical
5.6.1 International Biomedical Profile
5.6.2 International Biomedical Main Business
5.6.3 International Biomedical Nitric Oxide Therapy System Products, Services and Solutions
5.6.4 International Biomedical Nitric Oxide Therapy System Revenue (US$ Million) & (2018-2023)
5.6.5 International Biomedical Recent Developments
5.7 SLE
5.7.1 SLE Profile
5.7.2 SLE Main Business
5.7.3 SLE Nitric Oxide Therapy System Products, Services and Solutions
5.7.4 SLE Nitric Oxide Therapy System Revenue (US$ Million) & (2018-2023)
5.7.5 SLE Recent Developments
5.8 Mallinckrodt Pharmaceuticals
5.8.1 Mallinckrodt Pharmaceuticals Profile
5.8.2 Mallinckrodt Pharmaceuticals Main Business
5.8.3 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Products, Services and Solutions
5.8.4 Mallinckrodt Pharmaceuticals Nitric Oxide Therapy System Revenue (US$ Million) & (2018-2023)
5.8.5 Mallinckrodt Pharmaceuticals Recent Developments
5.9 Praxair,
5.9.1 Praxair, Profile
5.9.2 Praxair, Main Business
5.9.3 Praxair, Nitric Oxide Therapy System Products, Services and Solutions
5.9.4 Praxair, Nitric Oxide Therapy System Revenue (US$ Million) & (2018-2023)
5.9.5 Praxair, Recent Developments
5.10 Vapotherm
5.10.1 Vapotherm Profile
5.10.2 Vapotherm Main Business
5.10.3 Vapotherm Nitric Oxide Therapy System Products, Services and Solutions
5.10.4 Vapotherm Nitric Oxide Therapy System Revenue (US$ Million) & (2018-2023)
5.10.5 Vapotherm Recent Developments
5.11 Linde Group
5.11.1 Linde Group Profile
5.11.2 Linde Group Main Business
5.11.3 Linde Group Nitric Oxide Therapy System Products, Services and Solutions
5.11.4 Linde Group Nitric Oxide Therapy System Revenue (US$ Million) & (2018-2023)
5.11.5 Linde Group Recent Developments
6 North America
6.1 North America Nitric Oxide Therapy System Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nitric Oxide Therapy System Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nitric Oxide Therapy System Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nitric Oxide Therapy System Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nitric Oxide Therapy System Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nitric Oxide Therapy System Market Dynamics
11.1 Nitric Oxide Therapy System Industry Trends
11.2 Nitric Oxide Therapy System Market Drivers
11.3 Nitric Oxide Therapy System Market Challenges
11.4 Nitric Oxide Therapy System Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
